Clinical Trials Directory

Trials / Completed

CompletedNCT00623142

The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery

The Effects of Hyperbaric Oxygen Preconditioning On Cardiovascular Protection & Ischemic Reperfusion Injury

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Hull University Teaching Hospitals NHS Trust · Other Government
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to determine if treating patients who have coronary heart disease with hyperbaric oxygen (HBO) prior to coronary artery bypass graft (CABG) surgery reduces injury to the heart and vascular system during and after surgery. Furthermore, this study also aims to identify some of the post CABG clinical effects of HBO treatment prior to CABG.

Conditions

Interventions

TypeNameDescription
DRUGHyperbaric Oxygen100% Oxygen at 2.4 ATA for 30 minutes followed by 5 minutes break followed by 100% Oxygen at 2.4 ATA for another 30 minutes. This intervention was given about 4 to 5 hours prior to CABG

Timeline

Start date
2005-01-01
Primary completion
2007-01-01
Completion
2008-01-01
First posted
2008-02-25
Last updated
2019-07-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00623142. Inclusion in this directory is not an endorsement.

The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery (NCT00623142) · Clinical Trials Directory